ENANTA PHARMACEUTICALS
Enanta Pharmaceuticals, Inc., a research and development company, engages in the discovery, development, and promotion of small molecule drugs in the areas of anti-infective. It develops protease, NS5A, polymerase, and cyclophilin-based inhibitors for the treatment of hepatitis C virus (HCV). The company also develops ABT-450/r, an oral protease inhibitor for the treatment of hepatitis C (HCV) infection. In addition, it develops Bicyclolides, a macrolide antibiotic, which overcomes bacteri... al resistance; and EDP-420, a bicyclolide antibiotic for the treatment of community-acquired pneumonia. The company's antibacterial focus areas include superbugs, respiratory tract infections, and intravenous and oral treatments for hospital and community MRSA. The company has strategic alliances with Abbott Laboratories; and Shionogi & Co., LTD. Enanta Pharmaceuticals, Inc. was formerly known as NovirX, Inc. and changed its name to Enanta Pharmaceuticals, Inc. in May 1999. The company was founded in 1998 and is based in Watertown, Massachusetts.
ENANTA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.enanta.com
Total Employee:
51+
Status:
Active
Contact:
6176070530
Email Addresses:
[email protected]
Total Funding:
84.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Thuja Capital
Thuja Capital investment in Venture Round - Enanta Pharmaceuticals
Bioventures Investors
Bioventures Investors investment in Venture Round - Enanta Pharmaceuticals
Techno Venture Management
Techno Venture Management investment in Venture Round - Enanta Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Venture Round - Enanta Pharmaceuticals
Advent International
Advent International investment in Venture Round - Enanta Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Venture Round - Enanta Pharmaceuticals
Bioventures Investors
Bioventures Investors investment in Venture Round - Enanta Pharmaceuticals
Swiss Life Private Equity Partners
Swiss Life Private Equity Partners investment in Venture Round - Enanta Pharmaceuticals
Wheatley MedTech Partners
Wheatley MedTech Partners investment in Venture Round - Enanta Pharmaceuticals
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Venture Round - Enanta Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-08 | Enanta Pharmaceuticals Appoints Scott T. Rottinghaus, M.D., as Senior Vice President and Chief Medical Officer |
Official Site Inspections
http://www.enanta.com Semrush global rank: 226.61 K Semrush visits lastest month: 320.13 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Enanta Pharmaceuticals"
Governance - Enanta Pharmaceuticals
For an organization of our size, Enanta has a robust risk management program. This includes a security program, business continuity plan and a comprehensive set of other IT policies. The …See details»
Home - Enanta Pharmaceuticals
At Enanta, we are committed to creating important, novel medicines by pursuing bold ideas, employing rigorous research, and striving for scientific excellence in everything we do. We are …See details»
Corporate Responsibility Overview - Enanta Pharmaceuticals
Our disclosures reflect what is important within the context of Enanta: a small U.S. organization with less than 200 employees, two leased buildings, outsourced manufacturing and out …See details»
Enanta Pharmaceuticals - Crunchbase Company Profile & Funding
The company has strategic alliances with Abbott Laboratories; and Shionogi & Co., LTD. Enanta Pharmaceuticals, Inc. was formerly known as NovirX, Inc. and changed its name to Enanta …See details»
Committee Composition - Enanta Pharmaceuticals, Inc.
The Investor Relations website contains information about Enanta Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Enanta Pharmaceuticals, Inc. (ENTA) - Yahoo Finance
See the company profile for Enanta Pharmaceuticals, Inc. (ENTA) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Enanta Pharmaceuticals - Contacts, Employees, Board Members, …
Enanta Pharmaceuticals is an R&D company discovers, develops and promotes of small molecule drugs in the areas of anti-infective. ... Experience the new Crunchbase, powered by AI . …See details»
Investor FAQs | Enanta Pharmaceuticals, Inc.
Enanta’s corporate offices and research and development operations are located at: 4 Kingsbury Avenue Watertown, MA 02472 (617) 607-0800 Our website is www.enanta.com. When was …See details»
Investors | Enanta Pharmaceuticals, Inc.
Apr 8, 2025 Enanta Pharmaceuticals is a clinical stage biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule …See details»
About Us - Enanta Pharmaceuticals
Enanta is a clinical stage biotechnology company dedicated to creating oral drugs with an emphasis on indications in virology and immunology. Our story began in 1995 when we grew …See details»
ir.enanta.com
Ir.enanta.comSee details»
Enanta Pharmaceuticals - Craft
Oct 29, 2024 Enanta Pharmaceuticals has 5 employees at their 1 location and $67.64 m in annual revenue in FY 2024. See insights on Enanta Pharmaceuticals including office …See details»
Enanta Pharmaceuticals - Overview, News & Similar companies
May 6, 2024 Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. …See details»
Enanta Pharmaceuticals - Funding, Financials, Valuation & Investors
Enanta Pharmaceuticals is registered under the ticker NASDAQ:ENTA . Their stock opened with $14.00 in its Mar 21, 2013 IPO. Stock Symbol NASDAQ:ENTA ; Money Raised at IPO $56M; …See details»
Enanta Pharmaceuticals Inc: Overview - GlobalData
Enanta Pharmaceuticals Inc (Enanta) is a clinical-stage biotechnology company that develops small molecule drugs for viral and immune infections. The company’s pipeline products include …See details»
Social - Enanta Pharmaceuticals
Enanta participates in other activities including assembling birthday party kits for FamilyAid, a Greater Boston company that aids children and parents facing homelessness and donating …See details»
Enanta Pharmaceuticals Management Team | Org Chart
Enanta Pharmaceuticals employs 169 employees. The Enanta Pharmaceuticals management team includes Matt Kowalsky (Chief Legal Officer) , Ed O'Connell (Director, Business …See details»
Enanta Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical …
Apr 7, 2025 Enanta plans to expand its presence in immunology with the introduction of a third program in 2025. EPS-1421, Enanta’s lead candidate, is a novel, potent and selective oral …See details»
Contact Us - Enanta Pharmaceuticals
Contact. Enanta Pharmaceuticals, Inc. Headquarters 4 Kingsbury Avenue Watertown, MA 02472 (617) 607-0800 [email protected]See details»
ENANTA Pharmaceuticals, Inc. - MassBio
Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral …See details»